The analysis included: age at cancer diagnosis, time from RRSO to the diagnosis of cancer, significance of BRCA1 mutation type in patients diagnosed with breast or peritoneal cancer during postoperative follow-up. This evidence concerns the gene BRCA1 and peritoneum cancer.